Literature DB >> 7581220

Epidemiological study of epilepsy by monitoring prescriptions of antiepileptic drugs.

R Banfi1, G Borselli, C Marinai, A Borgheresi, A Cavalieri.   

Abstract

The aim of this study is to evaluate a simple and effective method of acquiring epidemiological information about epilepsy. Data on antiepileptic drug prescriptions was collected, the utilization pattern being based on defined daily doses (DDDs). Antiepileptic drugs are epidemiological tracers of epilepsy due to their chronic and highly specific usage. Consequently, a prevalence rate for the whole population may be obtained by using DDDs. Data on antiepileptic drug prescriptions for a period of 6 months in 1992 and 6 months in 1993 indicate a utilization of approximately 7 DDDs of antiepileptic drugs per 1,000 inhabitants. The prevalence of epilepsy was estimated by correcting the exposure calculated in DDDs by a factor of 0.68. In our sample, the prevalence of the disease was 5.2 per 1,000 inhabitants in 1992 and 4.9 per 1,000 in 1993. Physician prescriptions were concentrated on four compounds, namely phenobarbital, carbamazepine, valproic acid and phenytoin, which together represented 90% of total antiepileptic drug prescriptions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7581220     DOI: 10.1007/BF01872391

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  4 in total

Review 1.  Epidemiology, classification, natural history, and genetics of epilepsy.

Authors:  S D Shorvon
Journal:  Lancet       Date:  1990-07-14       Impact factor: 79.321

Review 2.  Epileptic seizures and syndromes.

Authors:  L Gram
Journal:  Lancet       Date:  1990-07-21       Impact factor: 79.321

3.  Descriptive epidemiologic study of epilepsy syndromes in a district of northwest Tuscany, Italy.

Authors:  C Maremmani; G Rossi; U Bonuccelli; L Murri
Journal:  Epilepsia       Date:  1991 May-Jun       Impact factor: 5.864

Review 4.  The long-term therapeutic management of epilepsy.

Authors:  J French
Journal:  Ann Intern Med       Date:  1994-03-01       Impact factor: 25.391

  4 in total
  5 in total

1.  Volume and market share of anti-epileptic drugs in The Netherlands: impact of new drugs.

Authors:  Pieter Knoester; Charles Deckers; Ronald van der Vaart; Bert Leufkens; Yechiel Hekster
Journal:  Pharm World Sci       Date:  2005-04

2.  Prescribing pattern of anti-epileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-07.

Authors:  Alessandro Oteri; Gianluca Trifirò; Maria Silvia Gagliostro; Daniele Ugo Tari; Salvatore Moretti; Placido Bramanti; Edoardo Spina; Achille Patrizio Caputi; Vincenzo Arcoraci
Journal:  Br J Clin Pharmacol       Date:  2010-10       Impact factor: 4.335

3.  Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany--a nationwide population-based study in children and adults.

Authors:  Hajo M Hamer; Richard Dodel; Adam Strzelczyk; Monika Balzer-Geldsetzer; Jens-Peter Reese; Oliver Schöffski; Wolfgang Graf; Stefan Schwab; Susanne Knake; Wolfgang H Oertel; Felix Rosenow; Karel Kostev
Journal:  J Neurol       Date:  2012-04-28       Impact factor: 4.849

4.  Use and safety profile of antiepileptic drugs in Italy.

Authors:  M L Iorio; U Moretti; S Colcera; L Magro; I Meneghelli; D Motola; A L Rivolta; F Salvo; G P Velo
Journal:  Eur J Clin Pharmacol       Date:  2007-02-16       Impact factor: 2.953

5.  Antiepileptic drugs prescription utilization behavior and direct costs of treatment in a national hospital of India.

Authors:  Ahsan Haroon; Manjari Tripathi; R Khanam; Divya Vohora
Journal:  Ann Indian Acad Neurol       Date:  2012-10       Impact factor: 1.383

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.